MyAverix Finance
SHE · Healthcare
PharmaBlock Sciences Nanjing Inc Class A (300725)
Drug Manufacturers - Specialty & Generic
PharmaBlock Sciences Nanjing Inc Class A (300725) is listed on SHE in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-28, reported market cap is $8.16B, P/E ratio is 34.90, net margin is 10.2%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 300725
PharmaBlock Sciences Nanjing Inc Class A (300725) — FAQ
What is PharmaBlock Sciences Nanjing Inc Class A's market cap?
PharmaBlock Sciences Nanjing Inc Class A (300725) has a reported market cap of $8.16B (data as of 2026-03-28).
What is 300725's P/E ratio?
The price-to-earnings (P/E) ratio for PharmaBlock Sciences Nanjing Inc Class A (300725) is 34.90 (data as of 2026-03-28).
Does PharmaBlock Sciences Nanjing Inc Class A pay a dividend?
Dividend yield is not available in the current snapshot for PharmaBlock Sciences Nanjing Inc Class A (300725). Check the MyAverix Finance app for the latest dividend data.
What sector is PharmaBlock Sciences Nanjing Inc Class A in?
PharmaBlock Sciences Nanjing Inc Class A (300725) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 300725 listed on?
300725 is listed on SHE.
What is PharmaBlock Sciences Nanjing Inc Class A's net margin?
PharmaBlock Sciences Nanjing Inc Class A (300725) reports a net margin of 10.2% (data as of 2026-03-28).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.